Tirilazad widens the therapeutic window for riluzole-induced attenuation of progressive cortical degeneration in an infant rat model of the shaken baby syndrome

Journal of Neurotrauma

Volumn 15, Issue 9, 1998, Pages 707-719

  Smith, Sarah L ^a   Hall, Edward D ^a  

^a PFIZER INC   (United States)

Author keywords

Cortical degeneration; Cortical hemorrhaging; Riluzole; Shaken baby syndrome; Tirilazad mesylate

Indexed keywords

RILUZOLE; TIRILAZAD;

ANIMAL EXPERIMENT; ARTICLE; BATTERED CHILD SYNDROME; BRAIN DEGENERATION; BRAIN HEMORRHAGE; CLINICAL FEATURE; DRUG EFFECT; DRUG PENETRATION; DRUG UPTAKE; HYPOXIA; LIPID PEROXIDATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT;

EID: 0031661398     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1998.15.707     Document Type: Article

References (54)

1. BAGENHOLM, R., ANDINE, P., and HAGBERG, H. (1996). Effects of the 21-aminosteroid (U-74006F) on brain damage and edema following perinatal hypoxia-ischemia in the rat. Pediatr. Res. 40, 399-403.
2. BENVENISTE, H., DREJER, J., SCHOUSBOE, A., and DIEMER, N.H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
3. CHOI, D.W. (1989). Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-469.
4. DIETRICH, W.D., ALONSO, O., HALLEY, M., BUSTO, R., and GLOBUS, M.Y. (1992). Intraventricular infusion of N-methyl-D-aspartate. 1. Acute blood-brain barrier consequences. Acta Neuropathol. (Berl.) 84, 621-637.
5. DOBLE, A. (1996). The pharmacology and mechanism of action of riluzole. Neurology 47, Suppl. 4, S233-S241.
6. DU, C., HU, R., HSU, C.Y., and CHOI, D.W. (1996). Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury. J. Neurotrauma 13, 215-222.
7. DUHAIME, A.C., ALARIO, A.J., LEWANDER, W.J., et al. (1992). Head injury in very young children: mechanisms, injury types, and ophthalmologic findings in 100 hospitalized patients younger than 2 years of age. Pediatrics 90, 179-185.
8. DUHAIME, A.C., SUTTON, L.N., and CHRISTIAN, C. (1996). Child abuse, in: Neurological Surgery. Vol. 3. J.R. Youmans (ed), W.B. Saunders: Philadelphia, pps. 1777-1791.
9. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
10. FLECK, T.J., and HALL, E.D. (1995). Neuroprotective effects of the 21-aminosteroid tirilazad mesylate and the pyrrolopyrimidine U-101033E following perinatal hypoxic-ischemic brain injury in the rat. J. Neurotrauma 12, 968.
11. GILLAND, E., PUKA-SUNDVALL, M., ANDINE, P., BONA, E., and HAGBERG, H. (1994). Hypoxic-ischemic injury in the neonatal rat brain: effects of pre-and post-treatment with the glutamate release inhibitor BW1003C87. Dev. Brain Res. 83, 79-84.
12. GRAFE, M.R. (1994). Developmental changes in the sensitivity of the neonatal rat brain to hypoxic/ischemic injury. Brain Res. 653, 161-166.
13. HAGBERG, H., GILLAND, E., DIEMER, N.-H., and ANDINE, P. (1994). Hypoxia-ischemia in the neonatal rat brain: Histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol. Neonate 66, 205-213.
14. HALL, E.D. (1988). Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats. J. Neurosurg. 68, 462-465.
15. HALL, E.D. (1996). Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage. Eur. J. Anaesthesiol. 13, 279-289.
16. HALL, E.D. (1997). Neuroprotective efficacy and mechanisms of the lazaroids, in: Handbook of Synthetic Antioxidants. L. Packer and E. Cadenas (eds), Marcel Dekker: New York, pps. 261-284.
17. HALL, E.D., ANDRUS, P.K., SMITH, S.L., et al. (1996). Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir. Suppl. (Wien) 66, 107-113.
18. HALL, E.D., ANDRUS, P.K., and YONKERS, P.A. (1993). Brain hydroxyl radical generation in acute experimental head injury. J. Neurochem. 60, 588-594.
19. HALL, E.D., and MCCALL, J.M. (1993). Lazaroids: Potent inhibitors of iron-dependent lipid peroxidation for neurode-generative disorders, in: Iron in Central Nervous System Disorders. P. Riederer and M.B.H. Youdim (eds), Springer-Verlag/Wien: Austria, pps. 173-188.
20. HALL, E.D., PAZARA, K.E., and BRAUGHLER, J.M. (1988). The 21-aminosteroid lipid peroxidation inhibitor U-74006F protects against cerebral ischemia in gerbils. Stroke 19, 997-1002.
21. HALL, E.D., and TRAVIS, M.A. (1988a). Effects of the non-glucocorticoid 21-aminosteroid U-74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage. Exp. Neurol. 102, 244-248.
22. HALL, E.D., and TRAVIS, M.A. (1988b). Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F. Brain Res. 451, 350-352.
23. HALL, E.D., YONKERS, P.A., HORAN, K.L., and BRAUGHLER, J.M. (1989). Correlation between attenuation of post-traumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism. J. Neurotrauma 6, 169-176.
24. IKONOMIDOU, C., MOSINGER, J.L., SHAHID SALLES, K., LABRUYERE, J., and OLNEY, J.W. (1989). Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9, 2809-2818.
25. IKONOMIDOU, C., QIN, Y., LABRUYERE, J., KIRBY, C., and OLNEY, J.W. (1996). Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr. Res. 39, 1020-1027.
26. IKONOMIDOU, C., and TURSKI, L. (1996). Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab. Brain Dis. 11, 125-141.
27. KANAMARU, K., WEIR, B.K.A., SIMPSON, I., WITBECK, T., and GRACE, M. (1991). Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J. Neurosurg. 74, 454-459.
28. KOENIG, H., TROUT, J.J., GOLDSTONE, A.D., and LU, C.Y. (1992). Capillary NMDA-receptor regulates blood-brain barrier function and breakdown. Brain Res. 588, 297-303.
29. MALGOURIS, C., BARDOT, F., DANIEL. M., et al. (1989). Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci. 9, 3720-3727.
30. MATHEW, P., BULLOCK, R., TEASDALE, G., and MCCULLOCH, J. (1996). Changes in local microvascular permeability and in the effect of intervention with 21-amino-steroid (Tirilazad) in a new experimental model of focal cortical injury in the rat. J. Neurotrauma 13, 465-472.
31. MCDONALD, J.W., and JOHNSTON, M.V. (1990). Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15, 41-70.
32. MCINTOSH, T.K. (1993). Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J. Neurotrauma 10, 215-261.
33. MCINTOSH, T.K., SMITH, D.H., VODDI, M., PERRI, B.R., and STUTZMANN, J.-M. (1996). Riluzole, a novel neuro-protective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J. Neurotrauma 13, 767-780.
34. MCINTOSH, T.K., VINK, R., SOARES, H., HAYES, R., and SIMON, R. (1990). Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J. Neurochem. 55, 1170-1179.
35. MUNNS, P.L., and LEACH, K.L. (1995). Two novel antioxidants, U74006F and U-78517F, inhibit oxidant-stimulated calcium influx. Free Rad. Biol. Med. 18, 467-478.
36. NAKAGOMI, T., KASSELL, N.F., SASAKI, T., et al. (1987). Effect of subarachnoid hemorrhage on endothelium-dependent vasodilation. J. Neurosurg. 66, 915-923.
37. NILSSON, P., HILLERED, L., PONTEN, U., and URGERSTEDT, V. (1990). Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10, 631-637.
38. PELLIGRINI-GIAMPIETRO, D.E., CHERICI, G., ALESIANI, M., CARLA, V., and MORONI, F. (1990). Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci. 10, 1035-1041.
39. POVLISHOCK, J.T. (1993). Traumatic brain injury. The pathobiology of injury and repair, in: Neurodegeneration. A. Gorio (ed), Raven Press: New York, pps. 185-216.
40. PRATT, J., RATAUD, J., BARDOT, F., et al. (1992). Neuro-protective actions of riluzole in rodent models of global and focal cerebral ischaemia. Neurosci. Lett. 140, 225-230.
41. + pump ATPase of human red blood cell membranes. Biochem. Pharmacol. 46, 525-534.
42. SASAKI, T., KASSELL, N.F., YAMASHITA, M., FUJIWARA, W., and ZUCCARELLO, M. (1985). Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J. Neurosurg. 63, 433-440.
43. SASAKI, T., KASSELL, N.F., ZUCCARELLO, M., et al. (1986). Barrier disruption in the major cerebral arteries during the acute stage after experimental subarachnoid hemorrhage. Neurosurgery 19, 177-184.
44. SCHMIDT, I., KAUL, R., and HELDMAIER, G. (1987). Thermoregulation and diurnal rhythms in 1-week-old rat pups. Can. J. Physiol. Pharmacol. 65, 1355-1364.
45. SMITH, S.L., ANDRUS, P.K., GLEASON, D.D., and HALL, E.D. (1998). Infant rat model of the shaken baby syndrome: Preliminary characterization for the role of free radicals in cortical hemorrhaging and progressive neuronal degeneration. J. Neurotrauma 15, 693-705.
46. SMITH, S.L., ANDRUS, P.K., ZHANG, J.-R., and HALL, E.D. (1994). Direct measurement of hydroxyl radicals, lipid peroxidation, and blood-brain barrier disruption following unilateral cortical impact head injury in the rat. J. Neurotrauma 11, 393-404.
47. SMITH, S.L., SCHERCH, H.M., and HALL, E.D. (1996). Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J. Neurosurg. 84, 229-233.
48. SPAIDE, R.F., SWENGEL, R.M., SCHARRE, D.W., and MEIN, C.E. (1990). Shaken baby syndrome. Am. Fam. Physician 41, 1145-1152.
49. TAYLOR, B.M., FLEMING, W.E., BENJAMIN, C.W., WU, Y., MATHEWS, W.R., and SUN, F.F. (1996). The mechanism of cytoprotective action of lazaroids. 1. Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J. Pharmacol. Exp. Ther. 276, 1224-1231.
50. VOLLMER, D.G., KASSELL, N.F., HONGO, K., OGWAWA, H., and SUKAHARA, T. (1989). Effect of the non-glucocorticoid 21-aminosteroid U-74006F on experimental cerebral vasospasm. Surg. Neurol. 31, 190-194.
51. WAHL, F., ALLIX, M., PLOTKINE, M., and BOULU, R.G. (1993). Effect of riluzole on focal cerebral ischemia in rats. Eur. J. Pharmacol 230, 209-214.
52. WAHL, F., PRATT, J., RENOU, E., MARY, V., GROSS, C., and STUTZMANN, J.-M. (1996). Neuroprotective effects of riluzole on brain trauma and spinal cord injury in rats. J. Neurotrauma 13, 627.
53. YANG, G., CHAN, P.H., CHEN, S.F., BABUNA, O.A., SIMON, R.P., and WEINSTEIN, P.R. (1994). Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia. Neurosurgery 34, 339-345.
54. ZUCCARELLO, M., and ANDERSON, D.K. (1989). Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 20, 367-371.